In this setting, the two additionally identified neoTCRs KIF-sc1 and -sc2 performed equally well compared to those previously known and reached complete tumor rejection in all mice with significantly prolonged survival (Fig. 4b, c). The gene discussed is TECR; the disease is neoplasm.